Skip to content

Welcome to Discover Pharma! Today is : October 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biologics

  • Advanced Therapies,Biotech & Pharma Business,Pharmaceuticals and therapeutics,Research & Development

    Eleva separates biologics platform from Factor H therapy

    Eleva is separating its moss-based biologics platform from its clinical-stage [...]

    September 15, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tezspire meets Phase 3 endpoints in eosinophilic esophagitis

    AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

    August 28, 2026
  • Drug Discovery & Development,Research & Development

    Anthropic AI protein designs undergo large-scale experimental validation

    Anthropic’s Claude AI models generated protein binders against 15 targets, [...]

    August 24, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Enzene launches local biomanufacturing model to cut biologics manufacturing costs

    Enzene has launched a biomanufacturing model designed to help governments [...]

    August 3, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    FDA approves Meitheal’s rapid-acting insulin biosimilar Garzulys

    The US Food and Drug Administration (FDA) has approved Meitheal [...]

    July 31, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development

    Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control

    Clean Cells has acquired French bioanalysis specialist Anaquant in a [...]

    July 30, 2026
  • Digital & Data,Drug Delivery & Formulation,Research & Development

    AI-driven antibody discovery could create $7bn market for life science tools

    AI-driven antibody discovery could create a $7 billion market opportunity [...]

    July 27, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza expands ADC drug product capacity in Switzerland

    Lonza is expanding its commercial-scale aseptic drug product capacity in [...]

    July 23, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas

    NEJM study provides first clinical evidence for NET-degrading therapy in lupus

    A study published in The New England Journal of Medicine [...]

    July 17, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Healome raises £2M to advance eye-drop technology for ocular surface diseases

    Healome Therapeutics has raised £2 million in seed funding to [...]

    July 8, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • E2 secures FDA clearance for pulmonary embolism thrombectomy system
    Categories: Clinical & Regulatory, Medical devices
  • Carterra and AstraZeneca target AI-driven drug discovery
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Research & Development
  • Biopharma dealmaking outlook improves despite investor caution
    Categories: Biotech & Pharma Business, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top